KAKEN PHARMACEUTICAL CO.,LTD., First Half Ordinary Profit Increases by 3.5 times, July-September Ordinary Profit Increases by 7.5 times

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Nov 8, 2024 3:30 pm JST Earnings

4521 KAKEN PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

KAKEN PHARMACEUTICAL CO.,LTD. <4521> [TSE-P] announced its financial results after the market closed on November 8th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) surged by 3.5 times that of the same period last year, reaching 19.8 billion yen. The progress rate against the 21.2 billion yen full-year plan was 93.5%, also surpassing the five-year average of 63.0%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to significant drop by 67.4% from the same period last year to 1.37 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit surged to 7.5 times that of the same period last year, reaching 16.8 billion yen. The operating profit margin jumped from 12.3% in the same period last year to 50.8%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	36,819	8,209	8,555	5,964	158.3	98.0	Nov 8, 2022	J-GAAP
Apr - Sep, 2023	36,171	5,512	5,722	4,068	108.2	57.5	Nov 8, 2023	J-GAAP
Apr - Sep, 2024	51,372	19,579	19,823	14,286	377.2	93.5	Nov 8, 2024	J-GAAP
YoY	+42.0%	+255.2%	+246.4%	+251.2%	+248.7%

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024 Guidance	ー	ー	ー	ー	－	115	Aug 7, 2024	J-GAAP
Apr - Sep, 2024 Results	51,372	19,579	19,823	14,286	377.2	115	Nov 8, 2024	J-GAAP
Revision Rate	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	35,873	4,001	4,229	3,957	104.9	75	May 14, 2024	J-GAAP
Oct - Mar, 2024 Guidance	37,128	1,221	1,377	-86	-2.3	75	Nov 8, 2024	J-GAAP
YoY	+3.5%	-69.5%	-67.4%	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	72,984	7,998	8,727	5,440	144.8	150	May 10, 2023	J-GAAP
Mar, 2024	72,044	9,513	9,951	8,025	212.7	150	May 14, 2024	J-GAAP
Mar, 2025 Guidance	88,500	20,800	21,200	14,200	374.9	190	Aug 7, 2024	J-GAAP
YoY	+22.8%	+118.6%	+113.0%	+76.9%	+76.3%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	18,021	2,219	2,234	1,558	41.4	12.3	Nov 8, 2023	J-GAAP
Oct - Dec, 2023	18,514	3,361	3,582	2,607	69.2	18.2	Feb 6, 2024	J-GAAP
Jan - Mar, 2024	17,359	640	647	1,350	35.8	3.7	May 14, 2024	J-GAAP
Apr - Jun, 2024	18,254	2,750	3,011	1,754	46.3	15.1	Aug 7, 2024	J-GAAP
Jul - Sep, 2024	33,118	16,829	16,812	12,532	330.9	50.8	Nov 8, 2024	J-GAAP
YoY	+83.8%	+658.4%	+652.6%	+704.4%	+698.7%